COPE Supported Centers Provide Innovative, Evidence-Based Psychiatric Ketamine and Esketamine (Spravato) Treatment.

COPE offers ketamine infusion therapy and intranasal esketamine (Spravato) for patients with treatment-resistant mental illnesses. COPE is proud to provide administrative and advisory support to highly specialized psychiatric clinics in multiple locations around the country that provide expert consultations and innovative, evidence-based psychiatric treatment for the most difficult to treat cases of major depression, anxiety, bipolar depression, chronic pain and opioid addiction among others.

Patients who come to our clinics have tried other treatments to no avail, and are looking for something more revolutionary than the standard protocol. If you or someone you love is suffering from one of these treatment-resistant mental illnesses, we encourage you to reach out to a COPE supported center near you to learn more about these innovative, effective, evidence-based treatments.

Download This Free Guide

“Depression By The Numbers— A Guide To Understanding Major Depression”